As of 2026-03-26, the Intrinsic Value of Pharmadrug Inc (PHRX.CN) is -0.01 CAD. This PHRX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Pharmadrug Inc is -175.10%.
Based on its market price of 0.01 CAD and our intrinsic valuation, Pharmadrug Inc (PHRX.CN) is overvalued by 175.10%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.01 - -0.01 | -0.01 | -175.10% |
| DDM - Stable | (0.05) - 0.13 | 0.04 | 301.7% |
| DDM - Multi | (3.11) - 5.90 | (12.66) | -126739.0% |
| Market Cap (mil) | 1.62 |
| Beta | -0.54 |
| Outstanding shares (mil) | 162.35 |
| Enterprise Value (mil) | 3.11 |
| Market risk premium | 5.10% |
| Cost of Equity | 3.98% |
| Cost of Debt | 5.00% |
| WACC | 4.30% |